Related Experiment Video
Updated: Apr 1, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus
Javier Perez-Hernandez1, Raquel Cortes1
1Genotyping and Genetic Diagnosis Unit, INCLIVA Biomedical Research Institute, Accesorio 4, Avenida Menendez Pelayo, 46010 Valencia, Spain ; Research Group of Cardiometabolic and Renal Risk, INCLIVA Biomedical Research Institute, Accesorio 4, Avenida Menendez Pelayo, 46010 Valencia, Spain.
Abstract:
Systemic lupus erythematosus is an autoimmune disease that predominantly affects women and typically manifests in multiple organs. The damage caused by this disorder is characterized by a chronic inflammatory state. Extracellular vesicles (EVs), including microvesicles (also known as microparticles), apoptotic bodies, and exosomes, are recognized vehicles of intercellular communication, carrying autoantigens, cytokines, and surface receptors. Therefore, the evidence of EVs and their cargo as biomarkers of autoimmune disease is rapidly expanding. This review will focus on biogenesis of extracellular vesicles, their pathophysiological roles, and their potential as biomarkers and therapeutics in inflammatory disease, especially in systemic lupus erythematosus.

